St Michael Mother Seeks Funds for Son's Life-Extending Stem Cell Therapy Abroad

A St Michael mother is desperately seeking funds for an experimental treatment abroad that could extend her son’s life and improve his cognitive abilities.

Tristan Thorpe, 20, has been diagnosed with microcephaly, a rare condition where the brain grows but the skull does not, leading to severe complications.

Sabrina Bovell told Barbados TODAY that her son requires innovative stem cell therapy, unavailable here, to be administered in Panama City. The treatment involves intravenous delivery of 80 million expanded allogeneic mesenchymal stem cells over five days, at a cost of US$17 825 ($35 650).

“After reading up on him and checking his reports, they said he’s a potential candidate for it and that they are willing to see how best they can help him and that’s all every parent wants, you know? To see their child improve,” Bovell said.

Tristan, from Pine, St Michael, was initially diagnosed with autism and speech delay at age three. Despite early interventions, Bovell noticed symptoms that seemed more severe than typical autism.

“When he was younger, the doctors said he was just going through typical developmental changes. But as he grew, it became clear there was something more severe,” she explained. “Through speech therapy, he began to say a few words like ‘head hurting’ and ‘stomach hurting’…. As a parent, you’d be concerned because this is not autism. This boy is trying to tell us a message.”

The underlying condition of microcephaly was ultimately diagnosed by geneticists at St Joseph University Hospital in Paterson, New Jersey.

“We ran some more tests and scans and they realised that he had inadequate head growth,” Bovell said. “They say that usually a [shunt] is placed in a child’s head and then taken out at 16 years old to give space in the brain but because we discovered Tristan’s condition so late, the prognosis is uncertain.”

Microcephaly is a neurodevelopmental disorder that is often associated with developmental delays and intellectual disabilities. The condition can arise from genetic or environmental factors, such as infections during pregnancy – like the Zika virus –that affect foetal brain development.

Allogeneic mesenchymal stem cells (MSCs) are a specific type of unique cells in an adult body that can serve as a sort of repair system, capable of dividing and renewing themselves for long periods. “Allogeneic” means that these stem cells are obtained from a donor rather than from the patient. Mesenchymal cells are derived from a donor’s bone marrow, fat, or umbilical cord tissue.

MSCs are considered to be particularly valuable in therapy because they can differentiate into various cell types. They have also been shown to have anti-inflammatory properties, which can help in healing and tissue repair.